LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells.

    Louvet, Loïc / Büchel, Janine / Steppan, Sonja / Passlick-Deetjen, Jutta / Massy, Ziad A

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2012  Volume 28, Issue 4, Page(s) 869–878

    Abstract: ... to investigate the effects of magnesium on Pi-induced VC at the cellular level using primary HAVSMC.: Methods ... Pi-induced VC in live HAVSMC, no effect was found in fixed cells. At potent concentrations in Pi ... phosphate levels. Inorganic phosphate (Pi) is a classical inducer of in vitro VC. Recently, an inverse ...

    Abstract Background: Vascular calcification (VC) is prevalent in patients suffering from chronic kidney disease. Factors promoting calcification include abnormalities in mineral metabolism, particularly high phosphate levels. Inorganic phosphate (Pi) is a classical inducer of in vitro VC. Recently, an inverse relationship between serum magnesium concentrations and VC has been reported. The present study aimed to investigate the effects of magnesium on Pi-induced VC at the cellular level using primary HAVSMC.
    Methods: Alive and fixed HAVSMC were assessed during 14 days in the presence of Pi with increasing concentrations of magnesium (Mg(2+)) chloride. Mineralization was measured using quantification of calcium, von Kossa and alizarin red stainings. Cell viability and secretion of classical VC markers were also assessed using adequate tests. Involvement of transient receptor potential melastatin (TRPM) 7 was assessed using 2-aminoethoxy-diphenylborate (2-APB) inhibitor.
    Results: Co-incubation with Mg(2+) significantly decreased Pi-induced VC in live HAVSMC, no effect was found in fixed cells. At potent concentrations in Pi-induced HAVSMC, Mg(2+) significantly improved cell viability and restored to basal level increased secretions of osteocalcin and matrix gla protein, whereas a decrease in osteopontin secretion was partially restored. The block of TRPM7 with 2-APB at 10(-4) M led to the inefficiency of Mg(2+) to prevent VC.
    Conclusions: Increasing Mg(2+) concentrations significantly reduced VC, improved cell viability and modulated secretion of VC markers during cell-mediated matrix mineralization clearly pointing to a cellular role for Mg(2+) and 2-APB further involved TRPM7 and a potential Mg(2+) entry to exert its effects. Further investigations are needed to shed light on additional cellular mechanism(s) by which Mg(2+) is able to prevent VC.
    MeSH term(s) Aorta/cytology ; Aorta/drug effects ; Aorta/metabolism ; Cell Survival/drug effects ; Cells, Cultured ; Humans ; Magnesium/pharmacology ; Minerals/metabolism ; Muscle, Smooth, Vascular/cytology ; Muscle, Smooth, Vascular/drug effects ; Muscle, Smooth, Vascular/metabolism ; Phosphates/metabolism ; Protein-Serine-Threonine Kinases ; TRPM Cation Channels/antagonists & inhibitors ; TRPM Cation Channels/metabolism ; Vascular Calcification/metabolism ; Vascular Calcification/pathology
    Chemical Substances Minerals ; Phosphates ; TRPM Cation Channels ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; TRPM7 protein, human (EC 2.7.11.1) ; Magnesium (I38ZP9992A)
    Language English
    Publishing date 2012-12-09
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfs520
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx.

    Herencia, Carmen / Rodríguez-Ortiz, M Encarnacion / Muñoz-Castañeda, Juan R / Martinez-Moreno, Julio Manuel / Canalejo, Rocío / Montes de Oca, Addy / Díaz-Tocados, Juan M / Peralbo-Santaella, Esther / Marín, Carmen / Canalejo, Antonio / Rodriguez, Mariano / Almaden, Yolanda

    European journal of clinical investigation

    2015  Volume 45, Issue 11, Page(s) 1129–1144

    Abstract: ... with a model of high phosphate (HP)-induced calcification in human aortic smooth muscle cells, which resembles ... phosphate-induced calcification in VSMCs, which appears mediated by the increase of magnesium influx and ... A reduction of magnesium entry into the HP-calcifying cells was found. The treatment with Ang II avoided ...

    Abstract Background: Vascular calcification (VC) is highly prevalent in patients with chronic kidney disease (CKD). Low magnesium levels are associated with VC, and recent in vitro studies confirm a protective role of magnesium, which is mediated by its entry into the VSMCs through the Transient Receptor Potential Melastatin 7 (TRPM7) channel. The role of Angiotensin II (Ang II) on VC is still unclear. As Ang II is able to stimulate TRPM7 activity, we hypothesize that it might prevent VC. Thus, the aim of this study was to dissect the direct effect of Ang II on VC.
    Materials and methods: We worked with a model of high phosphate (HP)-induced calcification in human aortic smooth muscle cells, which resembles the CKD-related VC.
    Results: Addition of Ang II to cells growing in HP decreased calcification, which was associated with the upregulation of the osteogenic factors BMP2, Runx2/Cbfa1, Osterix and ALP. A reduction of magnesium entry into the HP-calcifying cells was found. The treatment with Ang II avoided this reduction, which was reversed by the cotreatment with the TRPM7-inhibitor 2-APB. The protective effect of Ang II was related to AT1R-induced ERK1/2 MAPKinase activation. HP-induced calcification was also associated with the upregulation of the canonical Wnt/beta-catenin pathway, while its downregulation was related to attenuation of calcification by Ang II.
    Conclusion: As hypothesized, Ang II prevented phosphate-induced calcification in VSMCs, which appears mediated by the increase of magnesium influx and by the activation of the ERK1/2 and the inhibition of the canonical Wnt/beta-catenin signalling pathways.
    MeSH term(s) Alkaline Phosphatase/drug effects ; Alkaline Phosphatase/metabolism ; Angiotensin II/pharmacology ; Bone Morphogenetic Protein 2/drug effects ; Bone Morphogenetic Protein 2/metabolism ; Boron Compounds/pharmacology ; Cells, Cultured ; Core Binding Factor Alpha 1 Subunit/drug effects ; Core Binding Factor Alpha 1 Subunit/metabolism ; Humans ; MAP Kinase Signaling System/drug effects ; Magnesium/metabolism ; Muscle, Smooth, Vascular/cytology ; Muscle, Smooth, Vascular/drug effects ; Muscle, Smooth, Vascular/metabolism ; Myocytes, Smooth Muscle/drug effects ; Myocytes, Smooth Muscle/metabolism ; Protein Serine-Threonine Kinases/antagonists & inhibitors ; Protein Serine-Threonine Kinases/drug effects ; Protein Serine-Threonine Kinases/metabolism ; Sp7 Transcription Factor ; TRPM Cation Channels/antagonists & inhibitors ; TRPM Cation Channels/drug effects ; TRPM Cation Channels/metabolism ; Transcription Factors/drug effects ; Transcription Factors/metabolism ; Up-Regulation ; Vascular Calcification/metabolism ; Vasoconstrictor Agents/pharmacology ; Wnt Signaling Pathway/drug effects
    Chemical Substances BMP2 protein, human ; Bone Morphogenetic Protein 2 ; Boron Compounds ; Core Binding Factor Alpha 1 Subunit ; RUNX2 protein, human ; Sp7 Transcription Factor ; SP7 protein, human ; TRPM Cation Channels ; Transcription Factors ; Vasoconstrictor Agents ; Angiotensin II (11128-99-7) ; 2-aminoethoxydiphenyl borate (E4ES684O93) ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; TRPM7 protein, human (EC 2.7.11.1) ; Alkaline Phosphatase (EC 3.1.3.1) ; Magnesium (I38ZP9992A)
    Language English
    Publishing date 2015-09-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186196-7
    ISSN 1365-2362 ; 0014-2972 ; 0960-135X
    ISSN (online) 1365-2362
    ISSN 0014-2972 ; 0960-135X
    DOI 10.1111/eci.12517
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Magnesium Attenuates Phosphate-Induced Deregulation of a MicroRNA Signature and Prevents Modulation of Smad1 and Osterix during the Course of Vascular Calcification.

    Louvet, Loïc / Metzinger, Laurent / Büchel, Janine / Steppan, Sonja / Massy, Ziad A

    BioMed research international

    2016  Volume 2016, Page(s) 7419524

    Abstract: ... we demonstrated that magnesium (Mg(2+)) prevents inorganic phosphate- (Pi-) induced VC in human aortic ... vascular smooth muscle cells (HAVSMC). As microRNAs (miR) modulate gene expression, we investigated the role of miR-29b ... High phosphate levels promote VC by inducing abnormalities in mineral and bone metabolism. Previously ...

    Abstract Vascular calcification (VC) is prevalent in patients suffering from chronic kidney disease (CKD). High phosphate levels promote VC by inducing abnormalities in mineral and bone metabolism. Previously, we demonstrated that magnesium (Mg(2+)) prevents inorganic phosphate- (Pi-) induced VC in human aortic vascular smooth muscle cells (HAVSMC). As microRNAs (miR) modulate gene expression, we investigated the role of miR-29b, -30b, -125b, -133a, -143, and -204 in the protective effect of Mg(2+) on VC. HAVSMC were cultured in the presence of 3 mM Pi with or without 2 mM Mg(2+) chloride. Total RNA was extracted after 4 h, 24 h, day 3, day 7, and day 10. miR-30b, -133a, and -143 were downregulated during the time course of Pi-induced VC, whereas the addition of Mg(2+) restored (miR-30b) or improved (miR-133a, miR-143) their expression. The expression of specific targets Smad1 and Osterix was significantly increased in the presence of Pi and restored by coincubation with Mg(2+). As miR-30b, miR-133a, and miR-143 are negatively regulated by Pi and restored by Mg(2+) with a congruent modulation of their known targets Runx2, Smad1, and Osterix, our results provide a potential mechanistic explanation of the observed upregulation of these master switches of osteogenesis during the course of VC.
    MeSH term(s) Calcium/metabolism ; Cells, Cultured ; Gene Expression Regulation ; Humans ; Magnesium/administration & dosage ; MicroRNAs/metabolism ; Muscle, Smooth, Vascular/drug effects ; Muscle, Smooth, Vascular/metabolism ; Phosphates/administration & dosage ; Smad1 Protein/metabolism ; Sp7 Transcription Factor ; Transcription Factors/metabolism ; Vascular Calcification/metabolism
    Chemical Substances MicroRNAs ; Phosphates ; SMAD1 protein, human ; Smad1 Protein ; Sp7 Transcription Factor ; SP7 protein, human ; Transcription Factors ; Magnesium (I38ZP9992A) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2016-06-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2698540-8
    ISSN 2314-6141 ; 2314-6133
    ISSN (online) 2314-6141
    ISSN 2314-6133
    DOI 10.1155/2016/7419524
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Magnesium Attenuates Phosphate-Induced Deregulation of a MicroRNA Signature and Prevents Modulation of Smad1 and Osterix during the Course of Vascular Calcification

    Loïc Louvet / Laurent Metzinger / Janine Büchel / Sonja Steppan / Ziad A. Massy

    BioMed Research International, Vol

    2016  Volume 2016

    Abstract: ... we demonstrated that magnesium (Mg2+) prevents inorganic phosphate- (Pi-) induced VC in human aortic ... vascular smooth muscle cells (HAVSMC). As microRNAs (miR) modulate gene expression, we investigated the role of miR-29b ... High phosphate levels promote VC by inducing abnormalities in mineral and bone metabolism. Previously ...

    Abstract Vascular calcification (VC) is prevalent in patients suffering from chronic kidney disease (CKD). High phosphate levels promote VC by inducing abnormalities in mineral and bone metabolism. Previously, we demonstrated that magnesium (Mg2+) prevents inorganic phosphate- (Pi-) induced VC in human aortic vascular smooth muscle cells (HAVSMC). As microRNAs (miR) modulate gene expression, we investigated the role of miR-29b, -30b, -125b, -133a, -143, and -204 in the protective effect of Mg2+ on VC. HAVSMC were cultured in the presence of 3 mM Pi with or without 2 mM Mg2+ chloride. Total RNA was extracted after 4 h, 24 h, day 3, day 7, and day 10. miR-30b, -133a, and -143 were downregulated during the time course of Pi-induced VC, whereas the addition of Mg2+ restored (miR-30b) or improved (miR-133a, miR-143) their expression. The expression of specific targets Smad1 and Osterix was significantly increased in the presence of Pi and restored by coincubation with Mg2+. As miR-30b, miR-133a, and miR-143 are negatively regulated by Pi and restored by Mg2+ with a congruent modulation of their known targets Runx2, Smad1, and Osterix, our results provide a potential mechanistic explanation of the observed upregulation of these master switches of osteogenesis during the course of VC.
    Keywords Medicine ; R
    Subject code 500
    Language English
    Publishing date 2016-01-01T00:00:00Z
    Publisher Hindawi Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top